Tubersol

/ Medici

The recommended dosage per test is 0.1 ml of TUBERSOL, comprising 5 tuberculin units (TU).
See prescribing information for full details.

An aid in the detection of infection with mycobacterium tuberculosis.

Allergy to any component or to previous test,known tuberculin positive reactors, severe blistering tuberculin reaction in the past, extensive burns or eczema, active TB or treatment in the past.

Tubersol 250 U.S. units (TU) per test dose (0.1 ml) should not, under any circumstances, be used for the initial injection. Avoid injecting S.C. Do not inject I.V. Epinephrine HCl solution (1:1,000) and other appropriate agents should be available for immediate use in case an anaphylactic or acute reaction occurs. Before the use of this product, all appropriate precautions should be taken to prevent adverse reactions. Reactivity to the test may be depressed or suppressed for as long as 4 to 6 weeks in individuals who have had viral infections or in those who are receiving corticosteroids or immunosuppressive agents. Certain live virus vaccines may temporarily depress reactivity to PPD. Therefore, if a tuberculin test is to be performed it should be administered either before or at the same time as the live virus vaccines or wait at least 30 days before administering the test. In HIV-infected individuals, tuberculin skin test results are less reliable. Special care should be taken to ensure the product is not injected into a blood vessel. Since a tuberculin reactivity may not necessarily indicate the presence of active tuberculous disease, individuals showing a tuberculin reaction should be further evaluated with other diagnostic procedures.

Vesiculation, ulceration or necrosis may appear at the test site in highly sensitive persons. Pain, pruritus and discomfort may occur at the test site. Scarring at the test site. Rare systemic allergic reactions have been reported.